Nutromics

📍 Melbourne, Australia🗓 Founded 2017👥 64 employees💰 Last funded Jul 2024
Nutromics exists to save lives through continuous diagnostic monitoring. Current diagnostics offer only a delayed and limited snapshot of what is happening inside the body. We are changing that with the world’s first lab-on-a-patch®, a wearable device that delivers continuous, real-time molecular insights. Our platform technology uses AI-designed, DNA-based biosensors (aptamers) to track multiple critical molecular targets at once. This enables doctors to access real-time data on key markers, supporting faster decisions, more effective treatment, and better outcomes. Our first product focuses on the life-saving antibiotic vancomycin, with additional programs underway in sepsis, cardiology, and triage. Nutromics will eliminate the lag between symptom onset and diagnosis, providing doctors with immediate molecular data that helps prevent complications, reduce costs, and save lives.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2017
Founded
Investor geography2 countries
Singapore
1
United States
1
Frequently asked questions
Who invested in Nutromics?
Nutromics has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Nutromics last raise funding?
The most recent investment in Nutromics recorded on gritt.io was in July 2024.
When was Nutromics founded?
Nutromics was founded in 2017.
What industry is Nutromics in?
Nutromics operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Nutromics based?
Nutromics is headquartered in Melbourne, Australia.